(Total Views: 1147)
Posted On: 02/16/2018 4:28:46 PM
Post# of 105
$APRI trading stopped then resumed
down 67% closed $1.04
2/1/6/18
FDA cannot approve the NDA for Vitaros
in its present form, identifying deficiencies related to Chemistry,
Manufacturing and Control ("CMC"
and certain safety concerns specific
to the 2.5% concentration of DDAIP.HCl contained in the current
formulation.
down 67% closed $1.04
2/1/6/18
FDA cannot approve the NDA for Vitaros
in its present form, identifying deficiencies related to Chemistry,
Manufacturing and Control ("CMC"
and certain safety concerns specific to the 2.5% concentration of DDAIP.HCl contained in the current
formulation.
(0)
(0)
